Skip to main content
Log in

Benefits and Risks of Using Smart Pumps to Reduce Medication Error Rates: A Systematic Review

  • Systematic Review
  • Published:
Drug Safety Aims and scope Submit manuscript

Abstract

Background

Smart infusion pumps have been introduced to prevent medication errors and have been widely adopted nationally in the USA, though they are not always used in Europe or other regions. Despite widespread usage of smart pumps, intravenous medication errors have not been fully eliminated.

Objective

Through a systematic review of recent studies and reports regarding smart pump implementation and use, we aimed to identify the impact of smart pumps on error reduction and on the complex process of medication administration, and strategies to maximize the benefits of smart pumps.

Methods

The medical literature related to the effects of smart pumps for improving patient safety was searched in PUBMED, EMBASE, and the Cochrane Central Register of Controlled Trials (CENTRAL) (2000–2014) and relevant papers were selected by two researchers.

Results

After the literature search, 231 papers were identified and the full texts of 138 articles were assessed for eligibility. Of these, 22 were included after removal of papers that did not meet the inclusion criteria. We assessed both the benefits and negative effects of smart pumps from these studies. One of the benefits of using smart pumps was intercepting errors such as the wrong rate, wrong dose, and pump setting errors. Other benefits include reduction of adverse drug event rates, practice improvements, and cost effectiveness. Meanwhile, the current issues or negative effects related to using smart pumps were lower compliance rates of using smart pumps, the overriding of soft alerts, non-intercepted errors, or the possibility of using the wrong drug library.

Conclusion

The literature suggests that smart pumps reduce but do not eliminate programming errors. Although the hard limits of a drug library play a main role in intercepting medication errors, soft limits were still not as effective as hard limits because of high override rates. Compliance in using smart pumps is key towards effectively preventing errors. Opportunities for improvement include upgrading drug libraries, developing standardized drug libraries, decreasing the number of unnecessary warnings, and developing stronger approaches to minimize workarounds. Also, as with other clinical information systems, smart pumps should be implemented with the idea of using continuous quality improvement processes to iteratively improve their use.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Pang RKY, Kong DCM, deClifford JM, Lam SS, Leung BK. Smart infusion pumps reduce intravenous medication administration errors at an Australian teaching hospital. J Pharm Pract Res. 2011;41(3):192–5.

    Google Scholar 

  2. Snodgrass RD. Smart pump technology. Biomed Instrum Technol. 2005;39(6):444–6.

    PubMed  Google Scholar 

  3. Institute for Safe Medication Practices. “Smart” infusion pumps join CPOE and bar coding as important ways to prevent medication errors. http://www.ismp.org/Newsletters/acutecare/articles/20020207.asp. Accessed 3 Jun 2014.

  4. Institute for Safe Medication Practices. Proceedings from the ISMP Summit on the use of smart infusion pumps: guidelines for safe implementation and use: 1–19 http://www.ismp.org/tools/guidelines/smartpumps/printerversion.pdf. Accessed 3 Jun 2014.

  5. Murdoch LJ, Cameron VL. Smart infusion technology: a minimum safety standard for intensive care? Br J Nurs. 2008;17(10):630–6.

    Article  PubMed  Google Scholar 

  6. Mansfield J, Jarrett S. Using smart pumps to understand and evaluate clinician practice patterns to ensure patient safety. Hosp Pharm. 2013;48(11):942–50.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Pedersen CA, Schneider PJ, Scheckelhoff DJ. ASHP national survey of pharmacy practice in hospital settings: monitoring and patient education—2012. Am J Health Syst Pharm. 2013;70(9):787–803.

    Article  PubMed  Google Scholar 

  8. Rothschild JM, Keohane CA, Cook EF, et al. A controlled trial of smart infusion pumps to improve medication safety in critically ill patients. Crit Care Med. 2005;33(3):533–40.

    Article  PubMed  Google Scholar 

  9. Manrique-Rodriguez S, Sanchez-Galindo A, Fernandez-Llamazares CM, et al. Smart pump alerts: all that glitters is not gold. Int J Med Inform. 2012;81(5):344–50.

    Article  PubMed  Google Scholar 

  10. Williams CK, Maddox RR. Implementation of an i.v. medication safety system. Am J Health Syst Pharm. 2005;62(5):530–6.

    PubMed  Google Scholar 

  11. Trbovich PL, Pinkney S, Cafazzo JA, Easty AC. The impact of traditional and smart pump infusion technology on nurse medication administration performance in a simulated inpatient unit. Qual Saf Health Care. 2010;19(5):430–4.

    CAS  PubMed Central  PubMed  Google Scholar 

  12. Hertzel C, Sousa VD. The use of smart pumps for preventing medication errors. J Infus Nurs. 2009;32(5):257–67.

    Article  PubMed  Google Scholar 

  13. Manrique-Rodriguez S, Sanchez-Galindo AC, Lopez-Herce J, et al. Impact of implementing smart infusion pumps in a pediatric intensive care unit. Am J Health Syst Pharm. 2013;70(21):1897–906.

    Article  PubMed  Google Scholar 

  14. Malashock CM, Shull SS, Gould DA. Effect of smart infusion pumps on medication errors related to infusion device programming. Hosp Pharm. 2004;39(5):460–9.

    Google Scholar 

  15. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Fields M, Peterman J. Intravenous medication safety system averts high-risk medication errors and provides actionable data. Nurs Adm Q. 2005;29(1):78–87.

    Article  PubMed  Google Scholar 

  17. Wilson K, Sullivan M. Preventing medication errors with smart infusion technology. Am J Health Syst Pharm. 2004;61(2):177–83.

    PubMed  Google Scholar 

  18. Ohashi K, Dykes P, McIntosh K, Buckley E, Wien M, Bates DW. Evaluation of intravenous medication errors with smart infusion pumps in an academic medical center. AMIA Annu Symp Proc. 2013;2013:1089–98.

    PubMed Central  PubMed  Google Scholar 

  19. Russell RA, Murkowski K, Scanlon MC. Discrepancies between medication orders and infusion pump programming in a paediatric intensive care unit. Qual Saf Health Care. 2010;19(Suppl 3):i31–5.

    Article  PubMed  Google Scholar 

  20. Evans RS, Carlson R, Johnson KV, Palmer BK, Lloyd JF. Enhanced notification of infusion pump programming errors. Stud Health Technol Inform. 2010;160(Pt 1):734–8.

    PubMed  Google Scholar 

  21. Husch M, Sullivan C, Rooney D, et al. Insights from the sharp end of intravenous medication errors: implications for infusion pump technology. Qual Saf Health Care. 2005;14(2):80–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. Skledar SJ, Niccolai CS, Schilling D, et al. Quality-improvement analytics for intravenous infusion pumps. Am J Health Syst Pharm. 2013;70(8):680–6.

    Article  CAS  PubMed  Google Scholar 

  23. Fanikos J, Fiumara K, Baroletti S, et al. Impact of smart infusion technology on administration of anticoagulants (unfractionated heparin, argatroban, lepirudin, and bivalirudin). Am J Cardiol. 2007;99(7):1002–5.

    Article  CAS  PubMed  Google Scholar 

  24. Larsen GY, Parker HB, Cash J, O’Connell M, Grant MC. Standard drug concentrations and smart-pump technology reduce continuous-medication-infusion errors in pediatric patients. Pediatrics. 2005;116(1):e21–5.

    Article  PubMed  Google Scholar 

  25. Prewitt J, Schneider S, Horvath M, Hammond J, Jackson J, Ginsberg B. PCA safety data review after clinical decision support and smart pump technology implementation. J Patient Saf. 2013;9(2):103–9.

    Article  PubMed  Google Scholar 

  26. Nuckols TK, Bower AG, Paddock SM, et al. Programmable infusion pumps in ICUs: an analysis of corresponding adverse drug events. J Gen Intern Med. 2008;23(Suppl 1):41–5.

    Article  PubMed Central  PubMed  Google Scholar 

  27. Paul JE, Bertram B, Antoni K, et al. Impact of a comprehensive safety initiative on patient-controlled analgesia errors. Anesthesiology. 2010;113(6):1427–32.

    Article  PubMed  Google Scholar 

  28. Tran M, Ciarkowski S, Wagner D, Stevenson JG. A case study on the safety impact of implementing smart patient-controlled analgesic pumps at a tertiary care academic medical center. Jt Comm J Qual Patient Saf. 2012;38(3):112–9.

    PubMed  Google Scholar 

  29. Gerhart D, O’Shea K, Muller S. Advancing medication infusion safety through the clinical integration of technology. Hosp Pract (1995). 2013;41(4):7–14.

    Article  Google Scholar 

  30. Kastrup M, Balzer F, Volk T, Spies C. Analysis of event logs from syringe pumps: a retrospective pilot study to assess possible effects of syringe pumps on safety in a university hospital critical care unit in Germany. Drug Saf. 2012;35(7):563–74.

    Article  CAS  PubMed  Google Scholar 

  31. Bates DW, Leape LL, Cullen DJ, et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA. 1998;280:1311–6.

    Article  CAS  PubMed  Google Scholar 

  32. Poon EG, Keohane CA, Yoon CS, et al. Effect of bar-code technology on the safety of medication administration. N Engl J Med. 2010;362(18):1698–707.

    Article  CAS  PubMed  Google Scholar 

  33. Poon EG, Cina JL, Churchill W, et al. Medication dispensing errors and potential adverse drug events before and after implementing bar code technology in the pharmacy. Ann Intern Med. 2006;145:426–34.

    Article  PubMed  Google Scholar 

  34. Manrique-Rodriguez S, Sanchez-Galindo A, Fernandez-Llamazares CM, et al. Developing a drug library for smart pumps in a pediatric intensive care unit. Artif Intell Med. 2012;54(3):155–61.

    Article  PubMed  Google Scholar 

  35. Eastham J, Rizos A, Gama J, et al. Reduction in variation of intravenous drug administration in seventeen San Diego hospitals with standardized drug concentrations and dosage units. Hosp Pharm. 2009;44(2):150–8.

    Article  Google Scholar 

Download references

Acknowledgments

We thank Meaghan Muir for her support in searching the literature. We acknowledge founding support from the Association for the Advancement of Medical Instrumentation (AAMI) and Carefusion Foundation in 2012–2015 and Foundation Saint-Luc. Kumiko Ohashi, Patrica Dykes, and David Bates are funded by the AAMI and Carefusion Foundations to conduct a national smart pump study. Olivia Dalleur is funded by Foundation Saint-Luc and has no other conflict of interests. Dr. Bates serves on the board for SEA Medical Systems, which makes intravenous pump technology. He is on the clinical advisory board for Zynx, Inc., which develops evidence-based algorithms, and Patient Safety Systems, which provides a set of approaches to help hospitals improve safety. He consults for EarlySense, which makes patient safety monitoring systems. He receives equity and cash compensation from QPID, Inc., a company focused on intelligence systems for electronic health records. Dr. Bates’ financial interests have been reviewed by Brigham and Women’s Hospital and Partners HealthCare in accordance with their institutional policies.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kumiko Ohashi.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 119 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ohashi, K., Dalleur, O., Dykes, P.C. et al. Benefits and Risks of Using Smart Pumps to Reduce Medication Error Rates: A Systematic Review. Drug Saf 37, 1011–1020 (2014). https://doi.org/10.1007/s40264-014-0232-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40264-014-0232-1

Keywords

Navigation